GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Lifecore Biomedical
Lifecore Biomedical is a contract manufacturer of sterile injectable products. Its share price reflects growing demand for outsourced manufacturing from pharmaceutical and biotech companies, ensuring a stable order pipeline.
Share prices of companies in the market segment - Pharma tests
Lifecore Biomedical (LFCR) is a contract manufacturing organization (CDMO) for pharmaceutical companies, specializing in the sterile manufacturing of complex injectables and hyaluronic acid. We classify it under "Pharmaceutical Testing." The chart below reflects the dynamics of the pharmaceutical outsourcing sector.
Broad Market Index - GURU.Markets
Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in the production of sterile injectable products. As a component of the GURU.Markets index, it is a key partner for the pharmaceutical industry. The chart below represents the entire market. See how Lifecore's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
LFCR - Daily change in the company's share price Lifecore Biomedical
The daily price change of Lifecore, a contract manufacturer for the pharmaceutical industry, reflects the state of the biotech sector. Change_co measures volatility associated with demand for sterile injectables. This metric is an important element in analyzing pharmaceutical suppliers on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma tests
Lifecore Biomedical, Inc. is a contract manufacturer for the pharmaceutical industry. This chart shows the average daily volatility of the sector. Comparing it to LFCR, a key supplier, helps assess its stability compared to riskier biotech companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Lifecore is a contract manufacturing organization (CDMO) providing biologics development and manufacturing services. Its business depends on the health of the entire biotech industry. The chart below shows the volatility of this sector, helping to assess Lifecore's performance.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Lifecore Biomedical
Lifecore Biomedical's year-over-year performance tells the story of its role as a contract manufacturing organization (CDMO) for the pharmaceutical industry. Its 12-month market capitalization growth reflects demand for its sterile injectable manufacturing services, particularly hyaluronic acid, which provides it with stable revenue from long-term contracts with pharmaceutical companies.
Annual dynamics of market capitalization of the market segment - Pharma tests
Lifecore Biomedical, Inc. is a contract manufacturer of complex pharmaceutical products. Its expertise in producing sterile injectables makes it a valuable partner for the pharmaceutical industry. The chart below shows how its stable, contract-based business impacts its "defensive" performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Lifecore, as a contract manufacturer for the pharmaceutical industry, is a gold mine for the sector. Demand for its services is stable, as drug development continues. The company's stock performance demonstrates the resilience typical of companies providing scientific infrastructure.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Lifecore Biomedical
Lifecore, a contract pharmaceutical manufacturer, is valued based on its R&D cycles. The monthly fluctuations in the chart reflect demand for its sterile injectable manufacturing services from pharmaceutical and biotech companies, ensuring a stable order pipeline.
Monthly dynamics of market capitalization of the market segment - Pharma tests
The pharmaceutical contract manufacturing (CDMO) market is benefiting from growing R&D budgets in the industry. The dynamics of this sector, shown in the graph, reflect overall drug development activity. In this B2B environment, companies like Lifecore Biomedical are key partners for biotech companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Lifecore Biomedical, a contract manufacturing organization (CDMO) for the pharmaceutical industry, is benefiting from the growth of outsourcing in the sector. Demand for its services is stable and driven by R&D volumes. The company's stock can exhibit volatility not always associated with short market cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Lifecore Biomedical
Lifecore Biomedical, a contract manufacturer of sterile injectables for pharmaceutical companies, is a vital yet hidden player in the industry. Its weekly stock price reflects demand for manufacturing outsourcing from the biotech and pharmaceutical sectors, as well as its manufacturing capacity.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Pharmaceutical contract manufacturers like Lifecore Biomedical are a barometer of the health of the entire biotech sector. Demand for their services rises when the industry is booming. The chart below illustrates this overall trend, allowing us to assess how Lifecore benefits from these trends compared to other contract manufacturers.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Lifecore Biomedical is a contract manufacturer of sterile injectables for pharmaceutical companies. Its business is stable and has a high barrier to entry. The chart helps assess how well the company's shares, thanks to its niche, are protected from the strong volatility seen in the broader market.
Market capitalization of the company, segment and market as a whole
LFCR - Market capitalization of the company Lifecore Biomedical
Lifecore Biomedical's market capitalization is a measure of investors' assessment of its role as a contract manufacturer (CDMO) for the pharmaceutical industry. The chart shows how the market values its expertise in producing sterile injectables. Its value depends on its ability to attract and retain customers who trust it to manufacture their medications.
LFCR - Share of the company's market capitalization Lifecore Biomedical within the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) of complex pharmaceutical products, primarily sterile injectables. Its market capitalization in the pharmaceutical testing and manufacturing segment reflects its reputation as a reliable partner for biotech and pharmaceutical companies. The company's market share is growing in line with the trend toward outsourcing complex manufacturing.
Market capitalization of the market segment - Pharma tests
This graph shows the total value of the entire pharmaceutical sector. For Lifecore Biomedical, a contract manufacturer of sterile pharmaceuticals, this line represents the outsourcing map. A rising graph, particularly in biotech, signifies the emergence of many small companies without their own manufacturing facilities, creating enormous demand for the services of trusted partners like Lifecore.
Market capitalization of all companies included in a broad market index - GURU.Markets
Lifecore Biomedical is a contract manufacturer of sterile injectables. Its market capitalization is a proxy for the pharmaceutical industry's "hands." It reflects the market share of the business that helps other companies produce and bring drugs to market.
Book value capitalization of the company, segment and market as a whole
LFCR - Book value capitalization of the company Lifecore Biomedical
Lifecore Biomedical is a contract manufacturer (CDMO) for the pharmaceutical industry, specializing in sterile products. Its book value comes from its high-tech manufacturing facilities: aseptic filling lines and laboratories. How has this important infrastructure grown? The chart below shows.
LFCR - Share of the company's book capitalization Lifecore Biomedical within the market segment - Pharma tests
Lifecore Biomedical is a leading manufacturer of hyaluronic acid (HA). Its business is entirely based on its own FDA-certified manufacturing facility in Minnesota, where HA is fermented and purified. The chart shows its dominant share of the physical infrastructure for producing this important biomaterial.
Market segment balance sheet capitalization - Pharma tests
Lifecore Biomedical, a contract manufacturer for the pharmaceutical industry, is a highly capital-intensive business. It requires sterile manufacturing facilities certified to strict standards. The BCap_Seg sector chart demonstrates how demanding and demanding this industry is.
Book value of all companies included in the broad market index - GURU.Markets
Lifecore Biomedical's balance sheet consists of its FDA-certified manufacturing facilities, where it produces hyaluronic acid and sterilely fills injectables for other pharmaceutical companies. Its assets comprise its unique manufacturing base. The chart shows the physical weight of this contract manufacturer.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Lifecore Biomedical
Lifecore's balance sheet is its factory. The market pays a premium for its unique capabilities as a contract manufacturer of sterile injectables, a scarce and high-margin niche in the pharmaceutical industry. The schedule is a premium for expertise.
Market to book capitalization ratio in a market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer for pharmaceutical companies. It's a stable business. The chart shows how the market values its manufacturing expertise and long-term customer relationships, which provide predictable revenue.
Market to book capitalization ratio for the market as a whole
Lifecore Biomedical is a contract manufacturer of sterile injectable products. This business requires the highest quality standards and certified manufacturing facilities (physical assets). Its market valuation reflects its reputation and long-term contracts with pharmaceutical companies.
Debts of the company, segment and market as a whole
LFCR - Company debts Lifecore Biomedical
Lifecore Biomedical, a pharmaceutical contract manufacturer specializing in sterile injectable products, is using debt to expand its production capacity. This chart shows how the company is investing to meet growing demand from its customers, who require high-quality and reliable manufacturing.
Market segment debts - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) for pharmaceutical companies, specializing in sterile injectable products. This business requires significant investment in certified manufacturing facilities. This chart shows how the company uses debt to finance its capital-intensive production while serving pharmaceutical clients.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Lifecore Biomedical
Lifecore Biomedical is a contract manufacturer for pharmaceutical and medical device companies. Its business relies on orders from major players. This chart shows the company's financial structure. It helps assess how dependent it is on debt to finance its production facilities and how this impacts its stability.
Market segment debt to market segment book capitalization - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) of complex sterile injectable products for pharmaceutical companies. This business requires the highest quality standards. The chart shows debt trends in the sector, which helps understand how Lifecore finances its capital-intensive manufacturing facilities.
Debt to book value of all companies in the market
Lifecore Biomedical, a contract manufacturer for pharmaceutical companies, operates in a sector with high quality standards and stable demand. This chart shows the overall debt burden in the market. It allows one to assess how the company is using debt capital to expand its production capacity to meet the growing needs of the pharmaceutical industry.
P/E of the company, segment and market as a whole
P/E - Lifecore Biomedical
Lifecore Biomedical is a contract manufacturing organization (CDMO) for pharmaceutical and medical device companies, specializing in the production of sterile injectable products. This chart shows how the market perceives its manufacturing capabilities. The dynamics reflect the demand for outsourced manufacturing from the pharmaceutical industry.
P/E of the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer for pharmaceutical companies. This chart shows the average rating for the healthcare services sector. It helps understand whether Lifecore is receiving a premium for its expertise in producing complex injectables, for which demand from the pharmaceutical industry is constantly growing.
P/E of the market as a whole
Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the production of sterile injectable pharmaceutical products. This chart reflects general trends in the pharmaceutical industry. It allows investors to understand whether the LFCR valuation is aligned with overall pharmaceutical market growth, which is driving demand for outsourced manufacturing.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Lifecore Biomedical
Lifecore Biomedical is a contract manufacturer for pharmaceutical companies, specializing in sterile injectable products. Future profits are dependent on outsourcing trends in the pharmaceutical industry. This chart reflects market expectations for growth in demand for contract manufacturing services and the company's order book.
%20P%2FE%20Lifecore%20Biomedical&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Lifecore-Biomedical&v=1772555371866 "Chart of the company's future (projected) P/E Lifecore Biomedical")
Future (projected) P/E of the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in the manufacturing of sterile injectable pharmaceutical products such as syringes and vials. This graph reflects expectations for its future profitability, which depends on demand from pharmaceutical and biotech companies for its manufacturing capacity.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772555371893 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Lifecore Biomedical is a contract manufacturer (CDMO) for pharmaceutical companies, specializing in sterile injectable products. This overall expectations chart demonstrates that manufacturing outsourcing is a stable trend in the pharmaceutical industry, providing Lifecore with a steady flow of orders.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772555371939 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Lifecore Biomedical
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in the sterile production of complex pharmaceutical products, such as hyaluronic acid. This chart shows how the company earns money by helping other pharmaceutical companies bring their products to market. Profitability depends on the number and scale of customer contracts.
Profit of companies in the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer for pharmaceutical and medical device companies, specializing in sterile injectable products. Its business provides critical services to the pharmaceutical industry. The company's profitability depends on the volume of orders from its customers and is an indicator of activity in the drug manufacturing sector.
Overall market profit
Lifecore Biomedical is a contract manufacturer for pharmaceutical and medical device companies, specializing in sterile injectable products. Its business depends on activity in the pharmaceutical industry. This graph, reflecting the health of the corporate sector, influences the R&D budgets and production volumes of its clients, which directly impacts Lifecore's orders.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Lifecore Biomedical
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in the sterile production of complex pharmaceutical products. This chart shows analysts' expectations for future profits. The forecast depends on the company's ability to attract orders from pharmaceutical and biotech companies for the production of their injectables.
%20profit%20of%20the%20company%20Lifecore%20Biomedical&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Lifecore-Biomedical&v=1772555372049 "Graph of future (projected) profit of the company Lifecore Biomedical")
Future (predicted) profit of companies in the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturing organization (CDMO) for pharmaceutical companies, specializing in the production of sterile injectable products. The profitability forecasts for this sector, shown in the graph, reflect the growth of outsourcing in the pharmaceutical industry. This chart helps assess the importance of Lifecore's services in bringing new drugs to market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772555372066 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Lifecore Biomedical is a contract manufacturer (CDMO) for pharmaceutical and medical device companies, specializing in sterile injectable products. Demand for its services is driven by R&D and manufacturing activity in the pharmaceutical industry. The positive economic backdrop, reflected in this chart, supports a steady flow of orders from its clients.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772555372083 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Lifecore Biomedical
Lifecore Biomedical is a contract manufacturing organization (CDMO) for pharmaceutical companies, specializing in sterile injectable products. This chart shows how investors value its revenue. The stable valuation reflects the growing demand for outsourced manufacturing in the pharmaceutical industry and the company's strong position in its niche.
P/S market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) specializing in sterile injectable pharmaceutical products. This chart shows the average revenue estimate in the pharmaceutical industry. It helps assess the premium investors are willing to pay for the company's important role in the supply chain for pharmaceutical giants.
P/S of the market as a whole
Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in the production of sterile injectable pharmaceutical products. The company helps other pharmaceutical companies manufacture their medications. This chart shows how the market values the revenue of a service company in the pharmaceutical industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Lifecore Biomedical
Lifecore Biomedical is a contract manufacturer (CDMO) for pharmaceutical companies, specializing in sterile injectable products. This chart shows how investors estimate its future revenue. This valuation depends on its ability to secure new contracts and the growing demand for outsourced manufacturing in the pharmaceutical industry.
%20P%2FS%20Lifecore%20Biomedical&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Lifecore-Biomedical&v=1772555372238 "The graph of the company's future (projected) P/S Lifecore Biomedical")
Future (projected) P/S of the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) of sterile injectable pharmaceutical products. This chart compares the company's estimated future sales with other pharmaceutical testing companies. It shows how investors assess the demand for its services from biotech and pharmaceutical companies for the production of their drugs.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772555372263 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Lifecore Biomedical is a contract manufacturer of sterile injectable pharmaceutical products. Its clients include pharmaceutical and biotechnology companies. This overall outlook is important for Lifecore, as economic growth allows the pharmaceutical industry to invest more in the development and production of new drugs, increasing demand for its services.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772555372297 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Lifecore Biomedical
Here's a revenue chart for Lifecore Biomedical, a contract manufacturing organization (CDMO) for the pharmaceutical and medical device industries. It specializes in the production of sterile injectable products. Revenue growth reflects demand for manufacturing outsourcing from pharmaceutical companies and success in securing new manufacturing contracts.
Sales of companies in the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in the sterile production of complex pharmaceutical products, particularly those based on hyaluronic acid. This chart shows revenue in the pharmaceutical testing sector. It reflects the growing need for pharmaceutical companies to outsource complex manufacturing processes, where Lifecore offers its unique expertise.
Overall market sales
Lifecore Biomedical is a contract manufacturing organization (CDMO) for pharmaceutical companies, specializing in sterile injectable products. Demand for its services depends on activity in the pharmaceutical industry and the number of drugs in development. This overall economic activity indirectly impacts Lifecore, ensuring stable funding for its pharmaceutical clients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Lifecore Biomedical
Lifecore Biomedical is a contract manufacturer (CDMO) of complex sterile pharmaceutical products, particularly injectables. This projected revenue chart reflects the state of the biotech industry. The increase is driven by expectations of increased orders from pharmaceutical companies outsourcing the production of their innovative drugs.
%20sales%20of%20the%20company%20Lifecore%20Biomedical&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Lifecore-Biomedical&v=1772555372476 "Schedule of future (projected) sales of the company Lifecore Biomedical")
Future (projected) sales of companies in the market segment - Pharma tests
Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in the production of sterile injectable pharmaceutical products, such as hyaluronic acid. This chart shows projected revenue for the entire pharmaceutical testing sector, reflecting the demand for outsourced production of complex dosage forms.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772555372553 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Lifecore Biomedical is a contract manufacturer for pharmaceutical and medical device companies, specializing in sterile injectable products. Demand for its services depends on activity in the pharmaceutical industry. The stable economic growth projected for the region supports its clients' R&D budgets and production volumes.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772555372582 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Lifecore Biomedical
Lifecore Biomedical is a contract manufacturing organization (CDMO) that helps other pharmaceutical companies produce sterile injectable medications. Its profitability depends on the utilization of its manufacturing capacity. The chart shows how successfully the company secures long-term contracts and effectively manages its production.
Market segment marginality - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) specializing in the sterile production of complex pharmaceutical products such as syringes and vials. This chart shows the profitability of its manufacturing business. Low barriers to entry and deep expertise in aseptic manufacturing allow it to maintain high margins and long-term customer relationships.
Market marginality as a whole
Lifecore Biomedical is a contract manufacturer for pharmaceutical companies, specializing in sterile injectables. This overall cost-benefit curve impacts their customers. However, outsourcing manufacturing is a long-term trend in the pharmaceutical industry, ensuring Lifecore's stable demand.
Employees in the company, segment and market as a whole
Number of employees in the company Lifecore Biomedical
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in the sterile production of complex pharmaceutical products. This chart shows a team of highly qualified specialists. The growth in staff is directly related to the increase in contracts with pharmaceutical companies and the expansion of manufacturing capacity.
Share of the company's employees Lifecore Biomedical within the market segment - Pharma tests
Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in sterile injectable products. It's a service business, requiring a large staff of highly qualified specialists to operate under a strictly regulated environment. This metric reflects its manufacturing capacity, demonstrating its market share in the pharmaceutical outsourcing sector.
Number of employees in the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) for pharmaceutical companies, specializing in the production of sterile injectable products. This chart highlights an important, yet often invisible, part of the pharmaceutical industry. The growth of the company and its manufacturing staff is directly dependent on the success of its clients' products and the outsourcing of complex manufacturing processes.
Number of employees in the market as a whole
Lifecore Biomedical is a contract manufacturer of sterile injectable products for pharmaceutical companies. Its workforce growth is directly dependent on outsourcing trends in the pharmaceutical industry and the success of its clients' products. This chart shows how the sector serving big pharma is growing alongside it, providing critical manufacturing capacity.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Lifecore Biomedical (LFCR)
Lifecore Biomedical is a contract manufacturing organization (CDMO) that manufactures and fills syringes and vials of sterile injectables for pharmaceutical companies. This chart shows how the market rates the company's manufacturing excellence. The score is moderate, reflecting a balance between sophisticated equipment and highly skilled personnel.
%20of%20the%20company%20Lifecore%20Biomedical%20(LFCR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Lifecore-Biomedical-LFCR&v=1772555372932 "Chart of market capitalization per employee (in thousands of dollars) of the company Lifecore Biomedical (LFCR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO) for pharmaceutical companies, specializing in sterile injectable products. In this B2B segment, this metric reflects the level of technology and customer trust. A high capitalization per employee may indicate that the company works with complex, high-margin products for leading pharmaceutical companies.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772555372946 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Lifecore Biomedical is a contract manufacturer of sterile injectable products for pharmaceutical companies. This indicator reflects its niche and highly regulated nature. Value is created through manufacturing quality and compliance with standards. The market values its expertise and long-term customer contracts.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772555372963 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Lifecore Biomedical (LFCR)
Lifecore Biomedical is a CDMO (contract manufacturing organization) for the pharmaceutical industry. They specialize in the sterile production of injectables, particularly hyaluronic acid. This chart demonstrates the demand for their manufacturing. Their high profit per employee is a result of the high margins of their complex manufacturing services.
%20Chart%20Lifecore%20Biomedical%20(LFCR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Lifecore-Biomedical-LFCR&v=1772555372995 "Company Profit Per Employee (in thousands of dollars) Chart Lifecore Biomedical (LFCR)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in the development and manufacturing of sterile injectable products. It is a complex, high-margin service business. This metric reflects the productivity and profitability of their highly skilled staff in laboratories and on clean production lines.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772555373036 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in sterile injectables. They produce medications for other pharmaceutical companies. This chart shows their manufacturing efficiency: how cost-effectively their plant and team of specialists (chemists, operators) fulfill complex manufacturing contracts.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772555373050 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Lifecore Biomedical (LFCR)
Lifecore Biomedical is a contract manufacturing organization (CDMO) for pharmaceutical companies, specializing in sterile injectables. This chart shows the performance of its pharmaceutical services business. It reflects the revenue each employee generates from fulfilling manufacturing orders.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Lifecore-Biomedical-LFCR&v=1772555373084 "Sales chart per company employee Lifecore Biomedical (LFCR)")
Sales per employee in the market segment - Pharma tests
Lifecore Biomedical (LFCR) is a contract manufacturing organization (CDMO) for the pharmaceutical industry, specializing in the production of sterile injectables (e.g., hyaluronic acid). This chart shows how much revenue each employee generates at their plant. It's a direct indicator of production efficiency and capacity utilization.
Sales per employee for the market as a whole
Lifecore Biomedical (LFCR) is a contract manufacturing organization (CDMO) specializing in the sterile production of complex pharmaceutical products, particularly hyaluronic acid-filled syringes. This metric reflects how efficiently their high-tech, FDA-certified production lines generate revenue per employee.
Short shares by company, segment and market as a whole
Shares shorted by company Lifecore Biomedical (LFCR)
Lifecore Biomedical is a contract manufacturer (CDMO) specializing in sterile filling of injectables for pharmaceutical companies. This chart shows bearish bets. Bearish bets may be concerned about the company's dependence on a few large clients or quality issues in production that could lead to the loss of contracts.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Lifecore-Biomedical-LFCR&v=1772555373164 "Short Shares Chart for the Company Lifecore Biomedical (LFCR)")
Shares shorted by market segment - Pharma tests
Lifecore Biomedical is a contract manufacturer (CDMO). They produce complex sterile products (such as injectables) for other pharmaceutical companies. This chart shows short bets. "Shorts" here are bets that their clients (biotechs) will cut R&D budgets or that Lifecore will experience quality issues.
Shares shorted by the overall market
Lifecore Biomedical is a contract manufacturer (CDMO) of complex pharmaceutical products, such as injectable hyaluronic acid. This chart reflects the overall market pessimism. On the one hand, pharma is a defensive sector. But when fears mount, investors may worry that even large pharmaceutical companies will reduce their manufacturing outsourcing.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Lifecore Biomedical (LFCR)
Lifecore Biomedical (LFCR) is a contract manufacturer (CDMO). They specialize in producing sterile injectables (syringes, vials) for pharmaceutical companies. This chart measures momentum. It shows "overbought" (above 70) amid high demand for pharma outsourcing, or "oversold" (below 30) amid the loss of major clients.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Lifecore-Biomedical-LFCR&v=1772555373245 "RSI 14 indicator chart for the company's stock Lifecore Biomedical (LFCR)")
RSI 14 Market Segment - Pharma tests
Lifecore (LFCR) is a "B2B biotech." They contract manufacture (CDMO) sterile drugs (injectables, syringes) for other pharmaceutical companies. RSI_14_Seg for "Pharma Tests" (CDMO) indicates whether the sector is overheated. This helps distinguish whether LFCR's growth is due to their contracts or the general R&D boom in biotech.
RSI 14 for the overall market
Lifecore Biomedical (LFCR) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast LFCR (Lifecore Biomedical)
Lifecore Biomedical is a contract manufacturing organization (CDMO) specializing in the production of sterile injectable products, particularly hyaluronic acid. This chart shows the analysts' average 12-month forecast, reflecting their view of pharmaceutical companies' demand for outsourcing complex aseptic manufacturing.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-LFCR-Lifecore-Biomedical&v=1772555373351 "A chart showing analyst consensus forecasts for the expected stock price. LFCR (Lifecore Biomedical)")
The difference between the consensus estimate and the actual stock price LFCR (Lifecore Biomedical)
Lifecore Biomedical is a contract manufacturer (CDMO) specializing in sterile injectables, particularly hyaluronic acid. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting belief in the growth of outsourcing in the pharmaceutical industry.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-LFCR-Lifecore-Biomedical&v=1772555373402 "A chart showing the difference between the consensus forecast and the actual stock price. LFCR (Lifecore Biomedical)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Lifecore Biomedical is a CDMO (contract manufacturing organization). The company helps other pharmaceutical giants produce complex sterile injectables (such as hyaluronic acid). This chart shows general expectations for the pharma testing sector. It reflects whether experts believe outsourcing will increase in the production of complex drugs.
Analysts' consensus forecast for the overall market share price
Lifecore Biomedical is a contract manufacturer (CDMO) specializing in the production of sterile injectables and hyaluronic acid for pharmaceutical companies. This chart shows the overall market sentiment. For Lifecore, which operates behind the scenes in the protective pharmaceutical sector, the overall optimism is important, but their business is valued for its stability, as they produce already approved drugs.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Lifecore Biomedical
Lifecore Biomedical is a boutique contract manufacturing organization (CDMO) for the pharmaceutical industry. They specialize in the production of sterile injectables and, crucially, hyaluronic acid (HA) for ophthalmology and orthopedics. This chart assesses their manufacturing niche. It reflects their order book from pharmaceutical companies and their dominance in the medical hyaluronic acid market.
AKIMA Market Segment Index - Pharma tests
Lifecore (LFCR) is a leading B2B outsourcing company (CDMO) for the pharma industry, specializing in contract manufacturing of sterile, complex injectable products (including hyaluronic acid). This aggregate metric evaluates companies. The graph shows the sector average. This benchmark: how does this niche (B2B, injectable) model (LFCR) differentiate it from the average pharma company?
The AKIM Index for the overall market
Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in complex injectables. This chart, which reflects the market average, provides context. It helps assess how LFCR, a partner for pharmaceutical companies, compares to overall macroeconomic trends and demand for manufacturing capacity.
